Skip to main content
. 2020 Jan 27;111(2):441–450. doi: 10.1111/cas.14273

Table 4.

Circulating tumor cell EGFR upregulation compared to baseline value in patients with metastatic colorectal cancer treated with regorafenib (N = 50)

  Day 21 PD Day 21 and/or PD
Increased ≥0.01 ng/µL, n (%) 14 (28) 24 (48) 32 (64)
Stable/decreased, n (%) 36 (72) 17 (34) 18 (36)
P a .600 .041 .004

Abbreviation: PD, progressive disease.

a

Based on the sign test for paired data.